B. Wrackmeyer et al. / Inorganica Chimica Acta 358 (2005) 1420–1428
1427
MHz, CD2Cl2; 25 ꢁC): d = 38.0 (NCH3), 42.3 (NCH3).
11B NMR (80.3 MHz; CD2Cl2; 25 ꢁC): d = 37.6.
fc(NSiMe3)2Li2 (2) and BBr3 (1.33 mL of a 1.0 M solu-
tion in hexane, 1.33 mmol) to give 100 mg (17%) of 6 as
a yellow-orange oil.
4.3. Synthesis of the 1,3-bis(trimethylsilyl)-2-R-1,3,2-
diazabora-[3]ferrocenophanes
4.3.4.2. Method B. A solution of freshly prepared Br3B–
SMe2 (0.62 mmol) in hexane–CH2Cl2 was used in the
reaction with 2 (231 mg, 0.62 mmol) to give 131 mg
(47%) of 6 as a yellow-orange oil. 1H NMR (250.1
MHz; CD2Cl2,0 25 ꢁC): d = 0.22 (s, 18H, Me3Si), 3.86
4.3.1. 1,3-Bis(trimethylsilyl)-2-hydro-1,3,2-diazabora-[3]
ferrocenophane (3)
Freshly prepared fc(NSiMe3)2Li2 (2) (357 mg, 0.96
mmol) was taken up in hexane (20 mL); the suspension
was cooled to ꢀ70 ꢁC and HBBr2–SMe2 (0.96 mL of a
1.0 M solution in CH2Cl2, 0.96 mmol) was injected
slowly through a syringe. After stirring the reaction mix-
ture for 2 h at ꢀ70 ꢁC and then for 2 h at ambient tem-
perature, insoluble materials were seperated by
centrifugation and the clear liquid was collected. Vola-
tile materials were removed in vacuo (0.01 Torr) and
the resulting oil was dissolved in hexane (18 mL). After
filtration, the solvent was removed in vacuo to give 170
mg (48%) of 3 as a yellow solid. After 2 weeks at ꢀ30 ꢁC,
a few yellow needles of 3 crystallised at the glass wall.
These crystals (m.p. 65–67 ꢁC) were suitable for X-ray
structure determination. 1H{11B} NMR (250.1 MHz;
CD2Cl2; 25 ꢁC): d = 0.13 (s, 18H, Me3Si), 3.86 (m, 4H,
0
0
0
(m, 4H, H2;2 ;5;5 ), 4.00 (m, 4H, H3;3 ;4;4 ).
4.3.5. 1,3-Bis(trimethylsilyl)-2-phenoxy-1,3,2-diazabora-
[3]ferrocenophane (7)
The synthesis was carried out in the same way as for
3, starting from 380 mg (1.02 mmol) of fc(NSiMe3)2Li2
(2) and a solution of freshly prepared BCl2(OPh) (1.02
mmol) in hexane (4 mL) to give 240 mg (51%) of 7 as
a yellow-orange oil. Crystallisation from hexane at
ꢀ20 ꢁC gave yellow-orange crystals of 7 (m.p. 102–103
1
ꢁC). H NMR (250.1 MHz; CDCl3, 25 ꢁC): d = ꢀ0.05
0
0
(s, 18H, Me3Si), 3.95 (m, 4H, H2;2 ;5;5 ), 4.05 (m, 4H,
0
0
H3;3 ;4;4 ), 6.80 (m, 2H, Ph(Ho)), 6.93 (m, 1H, Ph(Hp)),
7.28 (m, 2H, Ph(Hm)).
0
0
0
0
H2;2 ;5;5 ), 3.99 (m, 4H, H3;3 ;4;4 ), 4.31 (br) (s, 1H, B–H).
4.3.6. 1,3-Bis(trimethylsilyl)-2-phenyl-1,3,2-diazabora-
[3]ferrocenophane (8)
4.3.2. 1,3-Bis(trimethylsilyl)-2-fluoro-1,3,2-diazabora-[3]
ferrocenophane (4)
The synthesis was carried out as described for 3 (2: 340
mg, 0.91 mmol; BCl2(Ph): 145 mg, 0.91 mmol) to give 220
mg (54%) of 8 as a orange oil. Crystallisation from hexane
at ꢀ30 ꢁC gave orange crystals of 8 (m.p. 148–150 ꢁC). 1H
NMR (250.1 MHz; CDCl3, 25 ꢁC): d = ꢀ0.32 (s, 18H,
The same procedure as for 3 was used (2: 214 mg,
0.57 mmol; BF3–OEt2, freshly distilled: 0.22 mL, 1.72
mmol). The resulting oil was dissolved in hexane (18
mL). After filtration from LiBF4, the solvent was re-
moved in vacuo to give 73 mg (33%) of 4 as a yellow so-
lid. Crystallisation from hexane, after 2 weeks at ꢀ30
ꢁC, gave yellow crystals of 4, m.p. 132–134 ꢁC (decom-
position). 1H NMR (250.1 MHz; CD2Cl2, 25 ꢁC):
0
0
0
0
Me3Si), 3.83 (m, 4H, H2;2 ;5;5 ), 4.02 (m, 4H, H3;3 ;4;4 ),
7.29 (m, 3H, Ph(Hm,p)), 7.42 (m, 2H, Ph(Ho)).
4.4. Synthesis of the 2,3-bis(dimethylamino)-1,4-bis(tri-
methylsilyl)-1,4-diaza-2,3-dibora-[4]ferrocenophane (9)
5
d = 0.090 (d, 18H, Me3Si, J(19F,1H) = 1.8 Hz), 3.89 (m,
0
0
0
4H, H2;2 ;5;5 ), 3.97 (m, 4H, H3;3 ;4;4 ).
The synthesis was carried out in analogy to that of 3,
starting from 342 mg (0.92 mmol) of fc(NSiMe3)2Li2 (2)
and 170 mg (0.92 mmol) of 1,2-bis(dimethylamino)dibo-
ron dichloride to give 268 mg (62%) of 9 as a red-orange
4.3.3. 1,3-Bis(trimethylsilyl)-2-chloro-1,3,2-diazabora-
[3]ferrocenophane (5)
1
The synthesis was carried out in analogy to that of 3,
starting from 120 mg (0.32 mmol) of fc(NSiMe3)2Li2 (2)
and BCl3 (0.32 mL of a 1.0 M solution in hexane, 0.32
oil. H NMR (250.1, 400 and 500.1 MHz; CDCl3; 25
ꢁC): d = 0.04 (s, 18H, Me3Si), 2.78 (br) (s, 6H, NCH3),
0
2.83 (br) (s, 6H, NCH3), 3.71 (m, 2H, H5;5 ), 3.83 (m,
0
0
0
1
mmol) to give 95 mg (73%) of 5 as a yellow oil. H
2H, H3;3 ), 3.89 (m, 2H, H4;4 ), 4.03 (m, 2H, H2;2 ). EI-
MS (70 eV) for C20H38N4B2Si2Fe (468.22): m/z
(%) = 468 (100) [M+], 351 (95) [M+ ꢀ (CH3)3-
SiN(CH3)2], 308 (13), 102 (15), 73 (19).
NMR (250.1 MHz; CDCl3, 25 ꢁC): d = 0.18 (s, 18H,
0
0
0
0
Me3Si), 3.83 (m, 4H, H2;2 ;5;5 ), 3.99 (m, 4H, H3;3 ;4;4 ). A
small amount of crystalline material of 5 with identical
NMR parameters had been obtained previously [6] as
a side product, which was characterised by X-ray analy-
sis in this work.
4.5. Crystal structure determinations of the 2-R-1,3,2-
diazabora-[3]ferrocenophanes
4.3.4. 1,3-Bis(trimethylsilyl)-2-bromo-1,3,2-diazabora-
[3]ferrocenophane (6)
4.3.4.1. Method A. The synthesis was carried out in anal-
ogy to that of 3, starting from 494 mg (1.33 mmol) of
Details pertinent to the crystal structure determina-
tions are listed in Table 3. Crystals of appropriate size
were sealed under argon in Lindemann capillaries. The
data collections were carried out at 20 ꢁC.